NCT03864081

Brief Summary

This study is designed as a repository study to collect resting cardiac phase signals and subject meta data from eligible subjects using the Phase Signal Recorder (PSR) prior to coronary angiography. The repository data will be used for the purposes of research, development, optimization and testing of machine-learning algorithms developed by Analytics 4 Life.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,500

participants targeted

Target at P75+ for not_applicable coronary-artery-disease

Timeline
Completed

Started Dec 2018

Typical duration for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 10, 2018

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

January 1, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 6, 2019

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

January 24, 2022

Status Verified

December 1, 2021

Enrollment Period

3.6 years

First QC Date

January 1, 2019

Last Update Submit

January 21, 2022

Conditions

Keywords

coronary angiographycoronary artery disease

Outcome Measures

Primary Outcomes (1)

  • Phase Signal Recorder Procedure

    Resting phase signals will be collected from eligible subjects prior to coronary angiography and paired with angiography results..

    7 day

Study Arms (1)

Enrolled Subjects (PSR)

OTHER

Patients who meet the study's inclusion and exclusion criteria, including signing the informed consent form, subjects will undergo signal acquisition prior to their scheduled cardiac catheterization on the day of the procedure.

Device: Phase Signal Recorder

Interventions

The Phase Signal Acquisition (PSAQ) System is a medical device system that is being developed to collect phase signals from patients to support the development and testing of machine learned algorithms. The PSAQ System consists of two components that work together to acquire and transmit the phase signals and patient specific data to a secured, cloud-based repository. The PSAQ System is comprised of: 1) the Phase Signal Recorder (PSR) which is a portable instrument, and 2) the Phase Signal Data Repository (PSDR) which is a cloud based data repository. Data collected during this study will not be used to guide treatment.

Also known as: PSR
Enrolled Subjects (PSR)

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients ≥ 18 years old;
  • Symptoms suggestive of obstructive CAD;
  • Scheduled to undergo cardiac catheterization with coronary angiography;
  • Ability to understand the requirements of the study and to provide written informed consent.

You may not qualify if:

  • Prior documented history of myocardial infarction (MI);
  • Suspected acute myocardial infarction (AMI) at current presentation;
  • Prior coronary artery bypass grafting (CABG);
  • Prior heart valve replacement;
  • Previous sustained or paroxysmal atrial or ventricular arrythmia;
  • Infiltrative myocardial disease (amyloid, sarcoid, right ventricular dysplasia);
  • Presence of cardiac implantable electronic device (CIED), including implantable cardioverter defibrillator (ICD), pacemaker (PM), implantable loop recorders and other monitors;
  • Implantable Neuro-stimulators;
  • Congenital Heart Disease;
  • Pregnant or breast feeding;
  • Currently taking any Type IA, IC or III antiarrhythmics;
  • Any history of amiodarone use;
  • Clinically significant chest deformity (e.g., pectus excavatum or pectus carinatum);
  • Breast implants;
  • Neuromuscular Disease if the condition results in tremor or muscle fasciculations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atlanta Heart Specialists

Cumming, Georgia, 30041, United States

RECRUITING

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • William E Sanders, Jr., MD JD LLM MBA FHRS

    Analytics For Life

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 1, 2019

First Posted

March 6, 2019

Study Start

December 10, 2018

Primary Completion

July 1, 2022

Study Completion

July 1, 2022

Last Updated

January 24, 2022

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations